Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.02 | 22.35 |
| PEG Ratio (TTM) | 0.03 | 4.32 |
| P/S Ratio (TTM) | 1.59 | 2.15 |
| P/B Ratio (TTM) | 2.09 | 2.60 |
| P/FCF Ratio (TTM) | N/A | 14.70 |
| Price to 5YR AVG Earnings Ratio | -0.90 | 7.42 |
| Price to 5YR AVG FCF Ratio | -1.52 | 31.38 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -10.59% | 6.89% |
| ROE (TTM) | -20.31% | 4.62% |
| Net Profit Margin (TTM) | -17.65% | 7.31% |
| ROIC 5YR AVG | -21.37% | 9.61% |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -897.65% | 32.04% | -0.78% |
| Revenue | 9.94% | -20.64% | -8.81% |
| Net Income | -903.39% | 33.48% | 257.10% |
| Cash Flow | -25.00% | -138.53% | 46.83% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.47 | 2.36 |
| Quick Ratio (TTM) | 1.46 | 2.26 |
| D/E Ratio (TTM) | 0.16 | 0.27 |
| Interest Coverage (TTM) | N/A | 138.94 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 4.40 |
| LTL to 5YR AVG FCF | -0.27 | 1.51 |
| Shares Outstanding Growth 5YR AVG | -19.83% | 30.93% |